Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway

Correction: Clinical Epigenetics (2018) 10:64 10.1186/s13148-018-0495-y

In the original publication of this article [1], there was an error in the Fig. 6. The MDA-MB-231 Invasion Cntl group in Fig. 6g and the MDA-MB-436 Migration Cntl group in Fig. 6h were wrongly chosen. The incorrect and correct Fig. 6 are shown in this correction article.

Fig. 6.

Knockdown of DNMT3B inhibited the proliferation, migration, and invasion in MDA-MB-231 and MDA-MB-436 cells. a Protein levels of DNMT3B detected by Western blotting in MDA-MB-231 cells after the transfection of DNMT3B siRNA 1 and 2. b Protein levels of DNMT3B detected by Western blotting in MDA-MB-436 cells after the transfection of DNMT3B siRNA 1 and 2. c Quantification of DNMT3B protein levels in MDA-MB-231 cells after the transfection of DNMT3B siRNA 1 and 2. d Quantification of DNMT3B protein levels in MDA-MB-436 cells after the transfection of DNMT3B siRNA 1 and 2. e CCK-8 proliferation assays of MDA-MB-231 cells after the transfection of DNMT3B siRNA. f CCK-8 proliferation assays of MDA-MB-436 cells after the transfection of DNMT3B siRNA. g Migration and invasion assays of MDA-MB-231 cells after the transfection of DNMT3B siRNA. h Migration and invasion assays of MDA-MB-436 cells after the transfection of DNMT3B siRNA. Data are presented as mean ± SD from three independent experiments, and every experiment was repeated three times

Incorrect Fig. 6.

Correct Fig. 6.